MFG
TMO icon

Merit Financial Group’s Thermo Fisher Scientific TMO Stock Holding History

Merit Financial Group’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11M Buy
21,998
+7,126
+48% +$3.42M 0.07% 241
2026
Q1 		$7.31M Sell
14,872
-632
-4% -$343K 0.05% 297
2025
Q4 		$8.98M Buy
15,504
+3,934
+34% +$2.22M 0.07% 219
2025
Q3 		$5.61M Sell
11,570
-333
-3% -$155K 0.05% 296
2025
Q2 		$4.83M Buy
11,903
+157
+1% +$65.6K 0.05% 288
2025
Q1 		$5.84M Buy
11,746
+1,895
+19% +$1.03M 0.09% 189
2024
Q4 		$5.12M Buy
9,851
+3,470
+54% +$1.91M 0.09% 180
2024
Q3 		$3.95M Sell
6,381
-2,061
-24% -$1.22M 0.09% 176
2024
Q2 		$4.67M Sell
8,442
-75
-0.9% -$43K 0.1% 155
2024
Q1 		$4.87M Buy
8,517
+4,723
+124% +$2.65M 0.12% 142
2023
Q4 		$2.01M Sell
3,794
-2,920
-43% -$1.41M 0.06% 207
2023
Q3 		$3.4M Buy
6,714
+310
+5% +$165K 0.11% 142
2023
Q2 		$3.34M Buy
6,404
+757
+13% +$409K 0.11% 145
2023
Q1 		$3.25M Buy
5,647
+64
+1% +$36.1K 0.12% 131
2022
Q4 		$3.07M Buy
5,583
+1,486
+36% +$787K 0.11% 138
2022
Q3 		$2.08M Sell
4,097
-1,952
-32% -$1.09M 0.09% 152
2022
Q2 		$3.29M Buy
6,049
+5,380
+804% +$2.96M 0.1% 130
2022
Q1 		$395K Buy
669
+23
+4% +$13.2K 0.02% 267
2021
Q4 		$431K Sell
646
-77
-11% -$48.1K 0.04% 184
2021
Q3 		$413K Buy
723
+100
+16% +$54.9K 0.04% 175
2021
Q2 		$314K Buy
623
+125
+25% +$59K 0.03% 203
2021
Q1 		$227K Sell
498
-125
-20% -$59.7K 0.02% 217
2020
Q4 		$290K Sell
623
-3
-0.5% -$1.41K 0.03% 172
2020
Q3 		$276K Buy
+626
New +$259K 0.03% 184

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Merit Financial Group's TMO Position: Q2 2026 in Review

Merit Financial Group increased its Thermo Fisher Scientific (TMO) stake by 48% in Q2 2026, buying an estimated $3.42M and bringing the position to 21,998 shares worth $11M. The position accounts for 0.07% of the portfolio, ranked #241.

Merit Financial Group first reported a position in TMO in Q3 2020 and has held it in 24 quarters since. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Merit Financial Group held 21,998 shares of Thermo Fisher Scientific worth $11M as of Q2 2026.
  • Merit Financial Group bought 7,126 Thermo Fisher Scientific shares in Q2 2026, an estimated $3.42M.
  • Thermo Fisher Scientific made up 0.07% of Merit Financial Group's portfolio in Q2 2026, its #241 holding.
  • Merit Financial Group first reported a position in Thermo Fisher Scientific in Q3 2020 and has held it in 24 quarters since.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Merit Financial Group's 13F filing for Q2 2026, filed 17 Jul 2026.